Mode
Text Size
Log in / Sign up
Phase 4 Completed N=45 Treatment

Bilateral Continuous Erector Spinae Blocks for Post-Sternotomy Pain Management

Source: ClinicalTrials.gov NCT04567407 ↗
Enrolled (actual)
45
Serious AEs
0.0%
Results posted
Oct 2023
Primary outcomePrimary: Analgesic Requirement — 0.60 (mg/kg)
◆ Published Evidence
Emerging
11citations · ~6 / year
Erector spinae plane blocks for opioid-sparing multimodal pain management after pediatric cardiac surgery.
The Journal of thoracic and cardiovascular surgery · 2024 · Likely link

Summary

To evaluate the efficacy of bilateral continuous erector spinae blocks (BESB) for postoperative analgesia in children and adolescents undergoing cardiac surgical procedures via sternotomy in the Early Recovery After Surgery (ERAS) program in a single arm, open label, interventional study.

Linked Publications

  • Erector spinae plane blocks for opioid-sparing multimodal pain management after pediatric cardiac surgery.
    The Journal of thoracic and cardiovascular surgery · 2024 · 11 citations · Likely link

Outcome Measures

OutcomeResultp-value
PRIMARY
Analgesic Requirement
1.34
SECONDARY
Duration of Mechanical Ventilation/Intubation
0.7
SECONDARY
Length of Postoperative ICU Stay
23.3
SECONDARY
Length of Hospital Stay
4.10
SECONDARY
Median Pain Scores
2.92
SECONDARY
Time to First Mobilization
6.75

Eligibility Criteria

Inclusion Criteria

  • Scheduled as part of the cardiac surgical ERAS program: Patients scheduled for elective surgeries for the following congenital anomalies, or similar: atrial septal defects (all types), partial anomalous pulmonary venous connection (non-obstructed), cor-triatriatum, VSD, partial AV canal, sub-aortic membrane resection, anomalous aortic origin of the coronary arteries, and pulmonary valve/conduit implantation
  • Scheduled for a primary sternotomy.
  • Ages 2 years through 17 years.

Exclusion Criteria

  • Single ventricle physiology.
  • Significant scoliosis or other anatomic contraindications to ESB.
  • Significant intraoperative hemodynamic instability or bleeding, as ascertained by clinicians taking care of the patient.
  • Patients with severe neurodevelopmental delays.
  • Patients with previous chronic pain syndromes.
  • Patients with a history of greater than 24 hours of postoperative or post-procedural opioid treatment at any point in the 2 months prior to surgery.
  • Lack of parental consent and/or child assent.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT04567407) and the linked publication. Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search